WAVA desires to expand the number collaborators over time and add academic faculty, public and private academic institutions, private research organizations, non-profits, commercial partners and governmental structures. WAVA’s vision is to become the world leader in effectual, rapid, cost-effective vaccine development and deployment. This is expected to occur by permitting member organizations to leverage each other’s expertise and facilities, and through mutually beneficial intellectual property policies.